Introducing the new Spruson & Ferguson brand
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a market leader in intellectual property services, and defines what will...
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a...
Read More
Infringement of second medical use claims | Federal Court decision adds guidance
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known substances arise frequently. In this article, we discuss the recent...
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known...
Read More
The shape of things to come?
Shape Trade Marks and RB (Hygiene Home) Australia Pty Ltd v Henkel Australia Pty Ltd FCAFC 10 A recent decision from the Full Court of the Federal Court of...
Shape Trade Marks and RB (Hygiene Home) Australia Pty Ltd v Henkel Australia Pty Ltd FCAFC 10 A recent...
Read More
The 2023 IP year in review, and predictions for 2024
In Australia, February signals a return from the beach, children back to school after a long summer break and of course the usual traffic woes! At Spruson & Ferguson Lawyers,...
In Australia, February signals a return from the beach, children back to school after a long summer break and...
Read More
No pay day for Commonwealth in Sanofi pharmaceutical damages claim
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal Court of Australia has upheld the trial judge’s decision that...
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal...
Read More

Contact our Expert Team

Contact Us
Contact Us